Date: 2017-07-06
Type of information: Capital increase
Company: Zealand Pharma (Denmark)
Investors:
Amount:
Funding type: capital increase
Planned used:
Others:
- • On July 6, 2017, Zealand Pharma announced that it has today filed a Form F-1 Registration Statement for a proposed initial public offering of American Depositary Shares. The Registration Statement relating to these securities has been filed with the U.S. Securities and Exchange Commission (the "SEC") but has not yet become effective.
- Application is being made to list the ADSs on the Nasdaq Global Select Market in the United States under the symbol "ZLND". In order to obtain authorization to issue the shares underlying the ADSs, Zealand will also send out a notice convening an Extraordinary General Meeting to authorize the Board of Directors to increase the Company's share capital.
Zealand's shares are currently listed on Nasdaq Copenhagen under the symbol ZEAL. The filing has no implications for Zealand's listing on Nasdaq Copenhagen in Denmark.
Therapeutic area:
Is general: Yes
